Report Detail

Pharma & Healthcare Global Diagnostic Radiopharmaceuticals & Contrast Media Market 2020 by Company, Regions, Type and Application, Forecast to 2025

  • RnM3881499
  • |
  • 14 February, 2020
  • |
  • Global
  • |
  • 107 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

Market Overview
The global Diagnostic Radiopharmaceuticals & Contrast Media market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.9% in the forecast period of 2020 to 2025 and will expected to reach USD 9594.6 million by 2025, from USD 8567.7 million in 2019.

The Diagnostic Radiopharmaceuticals & Contrast Media market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Diagnostic Radiopharmaceuticals & Contrast Media market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Diagnostic Radiopharmaceuticals & Contrast Media market has been segmented into:
Radiopharmaceuticals
Contrast Media

By Application, Diagnostic Radiopharmaceuticals & Contrast Media has been segmented into:
Diagnostic
Therapeutic
Ionizing Radiation based Radioimaging
Non-Ionizing Radiation based Radioimaging

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Diagnostic Radiopharmaceuticals & Contrast Media market presented in the report. This section sheds light on the sales growth of different regional and country-level Diagnostic Radiopharmaceuticals & Contrast Media markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Diagnostic Radiopharmaceuticals & Contrast Media market.

The report offers in-depth assessment of the growth and other aspects of the Diagnostic Radiopharmaceuticals & Contrast Media market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Diagnostic Radiopharmaceuticals & Contrast Media Market Share Analysis
Diagnostic Radiopharmaceuticals & Contrast Media competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Diagnostic Radiopharmaceuticals & Contrast Media sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Diagnostic Radiopharmaceuticals & Contrast Media sales, revenue and market share for each player covered in this report.

The major players covered in Diagnostic Radiopharmaceuticals & Contrast Media are:
Amag Pharmaceuticals
Mallinckrodt
Daiichi Sankyo
Bayer Healthcare
Lantheus
Bracco Imaging
Nordion
Guerbet
GE Healthcare
Medtronic


Table of Contents

    1 Diagnostic Radiopharmaceuticals & Contrast Media Market Overview

    • 1.1 Product Overview and Scope of Diagnostic Radiopharmaceuticals & Contrast Media
    • 1.2 Classification of Diagnostic Radiopharmaceuticals & Contrast Media by Type
      • 1.2.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Type: 2015 VS 2019 VS 2025
      • 1.2.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Type in 2019
      • 1.2.3 Radiopharmaceuticals
      • 1.2.4 Contrast Media
    • 1.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Market by Application
      • 1.3.1 Overview: Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Application: 2015 VS 2019 VS 2025
      • 1.3.2 Diagnostic
      • 1.3.3 Therapeutic
      • 1.3.4 Ionizing Radiation based Radioimaging
      • 1.3.5 Non-Ionizing Radiation based Radioimaging
    • 1.4 Global Diagnostic Radiopharmaceuticals & Contrast Media Market by Regions
      • 1.4.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Regions: 2015 VS 2019 VS 2025
      • 1.4.2 Global Market Size of Diagnostic Radiopharmaceuticals & Contrast Media (2015-2025)
      • 1.4.3 North America (USA, Canada and Mexico) Diagnostic Radiopharmaceuticals & Contrast Media Status and Prospect (2015-2025)
      • 1.4.4 Europe (Germany, France, UK, Russia and Italy) Diagnostic Radiopharmaceuticals & Contrast Media Status and Prospect (2015-2025)
      • 1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Diagnostic Radiopharmaceuticals & Contrast Media Status and Prospect (2015-2025)
      • 1.4.6 South America (Brazil, Argentina, Colombia) Diagnostic Radiopharmaceuticals & Contrast Media Status and Prospect (2015-2025)
      • 1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Diagnostic Radiopharmaceuticals & Contrast Media Status and Prospect (2015-2025)

    2 Company Profiles

    • 2.1 Amag Pharmaceuticals
      • 2.1.1 Amag Pharmaceuticals Details
      • 2.1.2 Amag Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.1.3 Amag Pharmaceuticals SWOT Analysis
      • 2.1.4 Amag Pharmaceuticals Product and Services
      • 2.1.5 Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Revenue, Gross Margin and Market Share (2018-2019)
    • 2.2 Mallinckrodt
      • 2.2.1 Mallinckrodt Details
      • 2.2.2 Mallinckrodt Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.2.3 Mallinckrodt SWOT Analysis
      • 2.2.4 Mallinckrodt Product and Services
      • 2.2.5 Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Revenue, Gross Margin and Market Share (2018-2019)
    • 2.3 Daiichi Sankyo
      • 2.3.1 Daiichi Sankyo Details
      • 2.3.2 Daiichi Sankyo Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.3.3 Daiichi Sankyo SWOT Analysis
      • 2.3.4 Daiichi Sankyo Product and Services
      • 2.3.5 Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Revenue, Gross Margin and Market Share (2018-2019)
    • 2.4 Bayer Healthcare
      • 2.4.1 Bayer Healthcare Details
      • 2.4.2 Bayer Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.4.3 Bayer Healthcare SWOT Analysis
      • 2.4.4 Bayer Healthcare Product and Services
      • 2.4.5 Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Revenue, Gross Margin and Market Share (2018-2019)
    • 2.5 Lantheus
      • 2.5.1 Lantheus Details
      • 2.5.2 Lantheus Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.5.3 Lantheus SWOT Analysis
      • 2.5.4 Lantheus Product and Services
      • 2.5.5 Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Revenue, Gross Margin and Market Share (2018-2019)
    • 2.6 Bracco Imaging
      • 2.6.1 Bracco Imaging Details
      • 2.6.2 Bracco Imaging Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.6.3 Bracco Imaging SWOT Analysis
      • 2.6.4 Bracco Imaging Product and Services
      • 2.6.5 Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Revenue, Gross Margin and Market Share (2018-2019)
    • 2.7 Nordion
      • 2.7.1 Nordion Details
      • 2.7.2 Nordion Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.7.3 Nordion SWOT Analysis
      • 2.7.4 Nordion Product and Services
      • 2.7.5 Nordion Diagnostic Radiopharmaceuticals & Contrast Media Revenue, Gross Margin and Market Share (2018-2019)
    • 2.8 Guerbet
      • 2.8.1 Guerbet Details
      • 2.8.2 Guerbet Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.8.3 Guerbet SWOT Analysis
      • 2.8.4 Guerbet Product and Services
      • 2.8.5 Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Revenue, Gross Margin and Market Share (2018-2019)
    • 2.9 GE Healthcare
      • 2.9.1 GE Healthcare Details
      • 2.9.2 GE Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.9.3 GE Healthcare SWOT Analysis
      • 2.9.4 GE Healthcare Product and Services
      • 2.9.5 GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Revenue, Gross Margin and Market Share (2018-2019)
    • 2.10 Medtronic
      • 2.10.1 Medtronic Details
      • 2.10.2 Medtronic Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.10.3 Medtronic SWOT Analysis
      • 2.10.4 Medtronic Product and Services
      • 2.10.5 Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Revenue, Gross Margin and Market Share (2018-2019)

    3 Market Competition, by Players

    • 3.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Share by Players (2015-2020)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 Diagnostic Radiopharmaceuticals & Contrast Media Players Market Share
      • 3.2.2 Top 10 Diagnostic Radiopharmaceuticals & Contrast Media Players Market Share
    • 3.3 Market Competition Trend

    4 Market Size by Regions

    • 4.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Market Share by Regions
    • 4.2 North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
    • 4.3 Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
    • 4.4 Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
    • 4.5 South America Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
    • 4.6 Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)

    5 North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Countries

    • 5.1 North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Countries (2015-2020)
    • 5.2 USA Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
    • 5.3 Canada Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
    • 5.4 Mexico Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)

    6 Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Countries

    • 6.1 Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Countries (2015-2020)
    • 6.2 Germany Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
    • 6.3 UK Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
    • 6.4 France Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
    • 6.5 Russia Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
    • 6.6 Italy Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)

    7 Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Countries

    • 7.1 Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Countries (2015-2020)
    • 7.2 China Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
    • 7.3 Japan Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
    • 7.4 Korea Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
    • 7.5 India Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
    • 7.6 Southeast Asia Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)

    8 South America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Countries

    • 8.1 South America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Countries (2015-2020)
    • 8.2 Brazil Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
    • 8.3 Argentina Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)

    9 Middle East & Africa Revenue Diagnostic Radiopharmaceuticals & Contrast Media by Countries

    • 9.1 Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Countries (2015-2020)
    • 9.2 Saudi Arabia Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
    • 9.3 UAE Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
    • 9.4 Egypt Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)
    • 9.5 South Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Growth Rate (2015-2020)

    10 Market Size Segment by Type

    • 10.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Market Share by Type (2015-2020)
    • 10.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Forecast by Type (2019-2024)
    • 10.3 Radiopharmaceuticals Revenue Growth Rate (2015-2025)
    • 10.4 Contrast Media Revenue Growth Rate (2015-2025)

    11 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Segment by Application

    • 11.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Application (2015-2020)
    • 11.2 Diagnostic Radiopharmaceuticals & Contrast Media Market Forecast by Application (2019-2024)
    • 11.3 Diagnostic Revenue Growth (2015-2020)
    • 11.4 Therapeutic Revenue Growth (2015-2020)
    • 11.5 Ionizing Radiation based Radioimaging Revenue Growth (2015-2020)
    • 11.6 Non-Ionizing Radiation based Radioimaging Revenue Growth (2015-2020)

    12 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size Forecast (2021-2025)

    • 12.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size Forecast (2021-2025)
    • 12.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Forecast by Regions (2021-2025)
    • 12.3 North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Forecast (2021-2025)
    • 12.4 Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Forecast (2021-2025)
    • 12.5 Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Forecast (2021-2025)
    • 12.6 South America Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Forecast (2021-2025)
    • 12.7 Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Forecast (2021-2025)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology
      • 14.2 Data Source
      • 14.3 Disclaimer

      Summary:
      Get latest Market Research Reports on Diagnostic Radiopharmaceuticals & Contrast Media. Industry analysis & Market Report on Diagnostic Radiopharmaceuticals & Contrast Media is a syndicated market report, published as Global Diagnostic Radiopharmaceuticals & Contrast Media Market 2020 by Company, Regions, Type and Application, Forecast to 2025. It is complete Research Study and Industry Analysis of Diagnostic Radiopharmaceuticals & Contrast Media market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,794.44
      4,191.66
      5,588.88
      3,267.72
      4,901.58
      6,535.44
      537,799.20
      806,698.80
      1,075,598.40
      290,858.40
      436,287.60
      581,716.80
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report